Back
Applied Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
74
APLT
Applied Therapeutics
Last Price:
9.63
Seasonality Move:
58.48%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Applied Therapeutics Price Quote
$9.63
+0.01 (+3.88%)
(Updated: November 23, 2024 at 5:25 AM ET)
Applied Therapeutics Key Stats
Buy
74
Applied Therapeutics (APLT)
is a Buy
Day range:
$8.95 - $9.64
52-week range:
$1.79 - $10.62
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
190.08%
Volume:
1.7M
Avg. volume:
1.7M
1-year change:
406.58%
Market cap:
$1.1B
Revenue:
$10M
EPS:
$-1.61
How Much Does Applied Therapeutics Make?
-
How Much Are Applied Therapeutics's Sales Annually?
APLT Revenues are $10M -
How Much Profit Does Applied Therapeutics's Make A Year?
APLT net income is -$119.8M
Is Applied Therapeutics Growing As A Company?
Data Unavailable
Applied Therapeutics Stock Price Performance
-
Did Applied Therapeutics Stock Go Up Last Month?
Applied Therapeutics share price went up by 10.38% last month -
Did APLT's Share Price Rise Over The Last Year?
APLT share price rose by 406.58% over the past 1 year
What Is Applied Therapeutics 52-Week High & Low?
-
What Is Applied Therapeutics’s 52-Week High Share Price?
Applied Therapeutics has traded as high as $10.62 over the past 52 weeks -
What Is Applied Therapeutics’s 52-Week Low Share Price?
Applied Therapeutics has traded as low as $1.79 over the past 52 weeks
Applied Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Applied Therapeutics?
-
How Much Debt Does Applied Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Applied Therapeutics Have?
Cash and short term investments quarterly total is $98.9M -
What Is Applied Therapeutics’s Book Value Per Share?
Book value per share is 0.05
Is Applied Therapeutics Cash Flow Positive?
-
What Is APLT Cash Flow From Operations?
Cash flow from operations (TTM) is -$81.8M -
What Is Applied Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $143.3M -
What Is Applied Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Applied Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
APLT return on invested capital is -790.52% -
What Is Applied Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -192.86% -
What Is APLT Return On Equity?
ROE is a measure of profitability and is -797.82%
Applied Therapeutics Earnings Date & Stock Price
-
What Is Applied Therapeutics's Stock Price Today?
A single share of APLT can be purchased today for 9.63 -
What Is Applied Therapeutics’s Stock Symbol?
Applied Therapeutics trades on the nasdaq under the ticker symbol: APLT -
When Is Applied Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Applied Therapeutics is scheduled on March 6, 2025 -
When Is APLT's next ex-dividend date?
Applied Therapeutics's next ex-dividend date is November 24, 2024 -
How To Buy Applied Therapeutics Stock?
You can buy Applied Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Applied Therapeutics Competitors
-
Who Are Applied Therapeutics's Competitors?
Below is a list of companies who compete with Applied Therapeutics or are related in some way:
Applied Therapeutics Dividend Yield
-
What Is APLT Dividend Yield?
Applied Therapeutics’s dividend yield currently is 0% -
What Is Applied Therapeutics’s Payout Ratio?
Applied Therapeutics’s payout ratio is 0% -
When Did Applied Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 24, 2024 -
What Is Applied Therapeutics’s Dividend Per Share?
Applied Therapeutics pays a dividend of $0.00 per share
Applied Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -195.49% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 14.67 |
| Upside from Last Price: | 52.38% |